In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Host:
Hongya Chen, PharmD, BCCP
Cardiology Clinical Pharmacist
Oregon Health & Science University
Portland, OR
Dr. Chen has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: BMS, MyoKardia
Faculty:
Jennifer L. Day, PharmD
Clinical Transplant Pharmacist
Baptist Health Heart Failure and Transplant Institute
Little Rock, AR
Dr. Day has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Janssen Pharmaceuticals
Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA
Gerald S. Berenson Endowed Chair
in Preventive Cardiology, Professor of Medicine
Tulane University School of Medicine
New Orleans, LA
Dr. Ferdinand has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Amgen, Boehringer-Ingelheim, Eli Lilly, Medtronic, Janssen Pharmaceuticals
Reviewers/Content Planners/Authors:
- Ann Early has nothing to disclose.
- Howard Green has nothing to disclose.
- Andrea Mathis has nothing to disclose.
- Tim Person has nothing to disclose.
- Susan Smith, MN, PhD has ownership interest in Hepion Pharmaceuticals.
- Mario Trucillo, PhD, MS, has nothing to disclose.